GSR
Glutathione reductase, mitochondrial
Also known as: GSHR_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P00390
- Gene
- GSR
- Ensembl
- ENSG00000104687
- Chromosome
- 8
- Canonical length
- 522 aa
- Protein class
- Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Cytosol
- Quaternary structure
- Homodimer
OverviewNCBI Gene
This gene encodes a member of the class-I pyridine nucleotide-disulfide oxidoreductase family. This enzyme is a homodimeric flavoprotein. It is a central enzyme of cellular antioxidant defense, and reduces oxidized glutathione disulfide (GSSG) to the sulfhydryl form GSH, which is an important cellular antioxidant. Rare mutations in this gene result in hereditary glutathione reductase deficiency. Multiple alternatively spliced transcript variants encoding different isoforms have been found. [provided by RefSeq, Aug 2010]
Canonical amino-acid sequenceUniProt
522 residues, UniProt reviewed canonical sequence.
>P00390|GSR
1 MALLPRALSA GAGPSWRRAA RAFRGFLLLL PEPAALTRAL SRAMACRQEP QPQGPPPAAG
61 AVASYDYLVI GGGSGGLASA RRAAELGARA AVVESHKLGG TCVNVGCVPK KVMWNTAVHS
121 EFMHDHADYG FPSCEGKFNW RVIKEKRDAY VSRLNAIYQN NLTKSHIEII RGHAAFTSDP
181 KPTIEVSGKK YTAPHILIAT GGMPSTPHES QIPGASLGIT SDGFFQLEEL PGRSVIVGAG
241 YIAVEMAGIL SALGSKTSLM IRHDKVLRSF DSMISTNCTE ELENAGVEVL KFSQVKEVKK
301 TLSGLEVSMV TAVPGRLPVM TMIPDVDCLL WAIGRVPNTK DLSLNKLGIQ TDDKGHIIVD
361 EFQNTNVKGI YAVGDVCGKA LLTPVAIAAG RKLAHRLFEY KEDSKLDYNN IPTVVFSHPP
421 IGTVGLTEDE AIHKYGIENV KTYSTSFTPM YHAVTKRKTK CVMKMVCANK EEKVVGIHMQ
481 GLGCDEMLQG FAVAVKMGAT KADFDNTVAI HPTSSEELVT LRLocalizationUniProt · AlphaFold · HPA
Whether an antibody against GSR can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.3
- Highest tissue expression
- 77 nTPM
Expression across tissuesHPA
Tissue
- parathyroid gland: 77 nTPM
- duodenum: 51 nTPM
- small intestine: 48 nTPM
- rectum: 44 nTPM
- kidney: 42 nTPM
- colon: 40 nTPM
Single-cell type
- neutrophil progenitors: 200 nCPM
- neutrophils: 151 nCPM
- monocyte progenitors: 127 nCPM
- prostatic glandular cells: 123 nCPM
- ocular epithelial cells: 118 nCPM
- platelets: 110 nCPM
Immune cell
- basophil: 32 nTPM
- eosinophil: 15 nTPM
- MAIT T-cell: 8.8 nTPM
- neutrophil: 8.2 nTPM
- non-classical monocyte: 8 nTPM
- myeloid DC: 6 nTPM
Brain region
- choroid plexus: 61 nTPM
- thalamus: 43 nTPM
- midbrain: 36 nTPM
- hippocampal formation: 33 nTPM
- hypothalamus: 33 nTPM
- amygdala: 32 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about GSR.
Disease | AllUniProt
Conditions GSR is implicated in, by any mechanism.
- Anemia, congenital, non-spherocytic hemolytic, 10 (CNSHA10) MIM:618660
Disease | GeneticClinVar
8 pathogenic / likely-pathogenic of 251 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.91
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.51
- DepMap mean gene effect
- -0.02
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- electron transfer activity
- flavin adenine dinucleotide binding
- NADP binding
- glutathione-disulfide reductase (NADPH) activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Pyridine nucleotide-disulphide oxidoreductase, class I
- Pyridine nucleotide-disulphide oxidoreductase, dimerisation domain
- Pyridine nucleotide-disulphide oxidoreductase, class I, active site
- FAD/NAD-linked reductase, dimerisation domain superfamily
- FAD/NAD(P)-binding domain
- FAD/NAD(P)-binding domain superfamily
- Glutathione reductase/thioredoxin reductase-like
- Pyridine nucleotide-disulphide oxidoreductase, dimerisation domain
- Pyridine nucleotide-disulphide oxidoreductase
- Glutathione reductase, eukaryote/bacterial
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads GSR as an antibody target. Whether an autoantibody or antibody against GSR could matter depends on whether native GSR is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
GSR is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label GSR as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...